Core Points - Kaldalón hf. has announced the implementation of a share buyback program authorized by shareholders on 2 July 2024 [1][2] - The company is allowed to repurchase up to 10% of its share capital, which amounts to a maximum of ISK 1,119,568,483 or 111,956,848 shares [2] - In 2024, Kaldalón repurchased 33,700,150 shares for ISK 613,868,947, and currently holds no treasury shares following a capital reduction [3] - The new buyback program aims to repurchase up to 15,000,000 shares for a total price not exceeding ISK 350,000,000 [3] - The program will start on 1 July 2025 and will continue until the purchase thresholds are met or by 31 December 2025 [4] - Íslandsbanki hf. will oversee the execution of the buyback program, making independent decisions regarding share repurchases [4] - The purchase price per share will not exceed the higher of the last independent transaction price or the highest current independent purchase offer [5] - Daily purchases will be limited to a maximum of 25% of the average daily trading volume over the preceding 20 trading days [5][6] - All transactions under the buyback program will be publicly disclosed in compliance with applicable laws [6]

6月30日获悉，知情人士表示，美国哈佛大学与白宫的谈判陷入僵局，这场僵局不仅威胁着学校的财政 状况，还扰乱了学校对外国学生的招生计划。据悉，尽管达成协议的希望仍然存在，但一项潜在的协议 已于上周被搁置，美国政府在致哈佛大学的一封信中表示，如果不立即做出足够的改变，将导致哈佛大 学"失去所有联邦财政资源"。近期，特朗普政府与哈佛大学之间冲突不断。特朗普政府威胁削减哈佛大 学数十亿美元研究资金。哈佛大学指责政府试图破坏学校的独立性。（央视） ...

Core Viewpoint - Rosen Law Firm has announced a class action lawsuit on behalf of purchasers of Hims & Hers Health, Inc. common stock during the specified Class Period, indicating potential legal issues surrounding the company's disclosures and partnerships [1][5]. Group 1: Class Action Details - The class action lawsuit is filed for purchasers of Hims common stock between April 29, 2025, and June 23, 2025, inclusive [1]. - Investors who purchased Hims stock during the Class Period may be entitled to compensation without any out-of-pocket fees through a contingency fee arrangement [2]. - Interested parties can join the class action by submitting a form or contacting the law firm directly [3][6]. Group 2: Allegations Against Hims - The lawsuit alleges that Hims made false and misleading statements regarding its partnership with Novo Nordisk A/S, particularly about the availability of the weight-loss drug Wegovy for Hims subscribers [5]. - Specific claims include that Hims failed to disclose the nature of its collaboration with Novo, which was supposed to ensure continued access to Wegovy, and that positive statements were made about the partnership that misled investors [5]. Group 3: Rosen Law Firm's Credentials - Rosen Law Firm has a strong track record in securities class actions, having achieved significant settlements, including the largest securities class action settlement against a Chinese company at the time [4]. - The firm has been consistently ranked among the top firms for securities class action settlements and has recovered hundreds of millions of dollars for investors [4].

Group 1 - City View Green Holdings Inc. announced a consolidation of its issued and outstanding common shares at a ratio of one (1) post-consolidated common share for every ten (10) pre-consolidated common shares [1][2][3] - The total number of outstanding shares will be reduced to approximately 45,681,347 common shares following the consolidation [1][3] - The name and symbol of the company will remain unchanged despite the share consolidation [2][4] Group 2 - All open orders will be canceled at the close of business on July 2, 2025, and dealers are advised to re-enter their orders considering the share consolidation [2][4] - Trading on a consolidated basis will commence on July 3, 2025, with the record date and anticipated payment date also set for July 3, 2025 [5] - The new CUSIP and ISIN for the consolidated shares are 178718201 and CA1787182015, respectively, while the old CUSIP and ISIN are 178718102 and CA1787181025 [5]

金十数据整理：中东局势跟踪（7月1日） 和谈情况： 1. 伊朗——①伊朗外交部：尚未决定与英国、法国和德国举行核谈判。②伊朗司法部门发言人表示，以 色列袭击伊朗造成的死亡人数已经上升到935人。 3. 美国——①美国总统特朗普计划于下周一在白宫会见以色列总理内塔尼亚胡。②白宫新闻秘书莱维 特：特朗普本人没有与伊朗进行过对话。中东问题特使威特科夫一直与伊朗方面保持联系。 其他： 1. 以军空袭加沙北部造成34人死亡。 跟踪中东局势动态 +订阅 2. 美总统特朗普签署行政令结束对叙利亚制裁。 3. 德国2025年将向乌克兰提供超90亿欧元援助。 4. 消息人士：伊拉克基尔库克空军基地遭到火箭袭击。 5. 以色列外长称有意与叙利亚和黎巴嫩建立正式外交关系。 6. 卡塔尔航空确认恢复对伊拉克、黎巴嫩、约旦和叙利亚的全部航班运营。 7. 美国国防部批准向以色列出售价值约5.1亿美元的弹药制导装置及弹药支持。 2. 以色列——以色列外长：以色列不会在任何和平协议中就戈兰高地进行谈判；周二，我们将在以色列 开始与欧盟对话。 ...

比特币直接画门，大涨大跌！昨日佩佩在文章《下周超级大变盘！比特币万点暴涨？SOL暴涨160，7月暴涨30%？这两个币要上天，知道就是赚到！》中 提示108000-109000期间可以做空，今早佩佩又在108700附近通知粉丝做空，暴赚74%！ 今早通知以太坊轻仓接空2500，2510止损 2560目标2450，2400,2350，ETH 稳健的可以止盈部分，公开和私聊都有发。 如果你昨天有看佩佩公众号或者问佩佩每日的开单策略，你应该和佩佩一样是吃到肉的，胜率大家可以明显看到，基本是全中胜率。现在每天吃香的喝辣 的！还没吃到肉的，佩佩带你布局，佩佩近期的大方向判断没有出错过。 BTC 文章来源：公众号佩佩梭哈 ETH 以太坊ETH 早盘突袭拉伸，再次冲击2520， 这是跌破2500后第二次反弹，主要是因为消息面带盘，炒作本周将迎来SEC对灰度数字大盘 ETF的最终审批 截止日期。 以太坊已形成结构性反转突破，当前构建回踩确认过程，关注FVG+OB重叠+前高区域2490–2480可多，上方留意2520-2550的供给区，2520测试两周，还 是没有上去阻力很大。 BTC日内在高点108888和低点107000区间 ...

Core Points - Thumzup Media Corporation has entered into a definitive agreement to purchase up to 1,083,333 shares of common stock at a price of $6.00 per share, aiming for gross proceeds of approximately $6.5 million before expenses [1] - The offering includes the issuance of 179,500 shares of Series C Convertible Preferred Stock, which are non-voting and have beneficial ownership limitations of 4.99% and 9.99% [1] - The net proceeds from the offering will be used for general corporate purposes and to explore accumulating other cryptocurrencies [1] Company Overview - Thumzup Media Corporation is focused on democratizing the social media branding and marketing industry, which is valued in the billions [4] - The company's flagship product, the Thumzup platform, allows users to earn cash for posting about participating advertisers on social media through a user-friendly app [4] - Advertisers can customize their campaigns using a programmatic advertiser dashboard, and payments to users are facilitated through digital payment systems like PayPal [4]

Core Viewpoint - Allbirds, Inc. has announced a comprehensive financing strategy aimed at optimizing working capital and enhancing financial flexibility to support long-term growth plans [1][2]. Financing Agreements - The company has established a new $75 million asset-based revolving credit facility, which includes a $50 million tranche and a $25 million accordion feature, replacing the previous $50 million facility [6]. - A sales agreement with TD Cowen allows the company to sell up to $50 million of Class A common stock through an At-the-Market (ATM) program [6]. - As of March 31, 2025, Allbirds reported $39.1 million in cash and cash equivalents, indicating a strong financial position [2]. Strategic Initiatives - The financing strategy supports Allbirds' initiatives to reignite product and marketing efforts, with new product launches expected in the coming weeks [2]. - The company plans to introduce over 15 new styles in its fall product lineup, focusing on modern design and unique materials [6]. - A new marketing strategy, under the "Allbirds by Nature" brand platform, aims to build long-term brand equity [6]. Operational Focus - Allbirds is committed to enhancing customer experience both online and in-store, with a store refresh program and a website redesign scheduled for July [6]. - The company emphasizes operational discipline and aims for long-term profitable growth while building durable value for shareholders [3].

Core Insights - Shoals Technologies Group, Inc. has released a webinar focused on Battery Energy Storage Systems (BESS) to educate stakeholders about the BESS market landscape and the company's solutions [1][2] Group 1: Webinar Details - The webinar aims to provide educational content for customers, investors, analysts, and other interested parties regarding the BESS market and Shoals' competitive position [2] - Featured speakers in the webinar include Mike Everson, BESS Account Executive, Matt Tractenberg, VP of Finance & Investor Relations, and Lindsey Williams, VP of Marketing & Communications [2] Group 2: Company Overview - Shoals Technologies Group is a leading provider of electrical balance of systems (EBOS) solutions for the energy transition market, recognized for its innovative technologies since its founding in 1996 [4] - The company focuses on enhancing installation efficiency, safety, system performance, and reliability for its customers in the renewable energy industry [4]

Core Points - Avicanna Inc. announced that all management nominees were elected as directors during the Annual General Meeting of Shareholders held on June 30, 2025 [1] - The shareholders approved the reappointment of Ramirez Jimenez International CPAs as auditors for the upcoming year [3] Company Overview - Avicanna is a biopharmaceutical company focused on developing, manufacturing, and commercializing plant-derived cannabinoid-based products for the global medical and pharmaceutical markets [4] - The company has a scientific platform that includes R&D and clinical development, leading to over thirty proprietary, evidence-based finished products [4] Product and Service Offerings - The RHO Phyto™ formulary offers a range of proprietary products including oral, sublingual, topical, and transdermal deliveries with varying cannabinoid ratios, currently available nationwide in Canada and expanding internationally [6] - MyMedi.ca is a medical cannabis care platform aimed at enhancing the patient journey, featuring a diverse product portfolio and bilingual pharmacist-led support programs [6] - Avicanna has developed a pipeline of proprietary cannabinoid-based candidates targeting unmet needs in dermatology, chronic pain, and neurological disorders [6] - The company’s subsidiary, Santa Marta Golden Hemp SAS, supplies high-quality CBD, THC, and CBG for various applications, forming part of Avicanna's supply chain [6]